Market closedNon-fractional

Amphastar Pharmaceuticals/AMPH

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Amphastar Pharmaceuticals

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Ticker

AMPH

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Rancho Cucamonga, United States

Employees

1,761

AMPH Metrics

BasicAdvanced
$1.8B
Market cap
12.93
P/E ratio
$2.91
EPS
0.85
Beta
-
Dividend rate
$1.8B
0.85
2.175
1.679
92.621
93.271
5.98%
11.26%
25.34%
12.93
2.69
2.72
28.06
11.28
30.38%
64.18%
22.46%
282.57%

What the Analysts think about AMPH

Analyst Ratings

Majority rating from 6 analysts.
Buy

AMPH Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
25.08% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$172M
-3.54%
Net income
$43M
19.39%
Profit margin
25.08%
23.79%

AMPH Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 8.65%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.65
$1.15
$0.88
$1.04
-
Expected
$0.56
$0.69
$0.93
$0.96
$0.80
Surprise
16.02%
65.53%
-4.93%
8.65%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Amphastar Pharmaceuticals stock?

Amphastar Pharmaceuticals (AMPH) has a market cap of $1.8B as of July 05, 2024.

What is the P/E ratio for Amphastar Pharmaceuticals stock?

The price to earnings (P/E) ratio for Amphastar Pharmaceuticals (AMPH) stock is 12.93 as of July 05, 2024.

Does Amphastar Pharmaceuticals stock pay dividends?

No, Amphastar Pharmaceuticals (AMPH) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Amphastar Pharmaceuticals dividend payment date?

Amphastar Pharmaceuticals (AMPH) stock does not pay dividends to its shareholders.

What is the beta indicator for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals (AMPH) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Amphastar Pharmaceuticals stock

Buy or sell Amphastar Pharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing